DNA repair of adriamycin induced damage in mouse and human cells differing in catalase activity.

  • B M Gruber Department of Vitamin Drugs, Drug Institute, Warsaw, Poland.;
  • E L Anuszewska

Abstract

Catalase is known to counteract cytotoxic effect of adriamycin, used as an anti-neoplastic drug. In cells with low catalase activity no repair of adriamycin induced lesions was observed up to 48 h post treatment. In cells with high catalase activity after 48 h the repair was either complete or partial depending on the human or mouse cell type used.
Published
1998-06-30
Section
Articles